Subscribe to our Newsletters !!
Early and accurate pathogen identification is esse
Nonstop exploration of new technologies in the bio
Carrying forward its legacy of advancing the count
BOLTON, Ontario – Husky TechnologiesTM, a pionee
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
Following the success of the promotion and informa
High-performance liquid chromatography (HPLC) digi
Dr. Krishna Ella, the founder of Bharat Biotech, advocated on Friday for “research connected incentives” and tax breaks for new goods based on ground-breaking and patented invention carried out within the nation.
“Research linked incentive for Indian companies is very important. I would request the ministry to give tax breaks to any product that is created from patent filed in India. It will inspire entrepreneurs to go for innovation,” he said.
Dr. V. G. Somani, the Drugs Controller General of India, said the Center was ready to launch a research-linked incentive programme to support the development of biotech products in the nation. The programme will be modelled after the production-linked incentive (PLI) scheme, which was discussed at the 72nd IPC here earlier in the day.
When asked why there should be three doses of the COVID-19 vaccine rather than one, Ella responded that his company was looking into the matter.
Delegates from India and beyond will attend the three-day Indian Pharmaceutical Congress, which will discuss a variety of topics pertaining to the industry, academics, and community pharmacy. PTI
